Backgrounds/Aims: Intrahepatic recurrence is one of the most important causes of compromised prognosis after surgical resection of hepatocellular carcinoma (HCC). This retrospective study was designed to identify and compare the risks of recurrence, early recurrence and multiple recurrences in a single patient population. Methods: A series of 92 consecutive patients, who received resection for single nodular HCC at our institute from January 2007 to December 2013, were enrolled in this study. The patients were divided into recurrent and non-recurrent groups; the recurrent group was further divided into subgroups by applying two criteria: early and late recurrence (with a cutoff of 18 months), and single and multiple (≥2) recurrence. The potential risk factors were compared using univariate and multivariate analyses. The subgroup analysis was performed to determine the effects of different cut-off values on the analysis. Results: 41 recurrences (44.6%) occurred during a mean follow-up of 42.4 months. The Child-Pugh score, and the portal vein invasion were found to be independent risk factors of recurrence, but differentiation was the only independent risk factor of early recurrence. The serum alpha-fetoprotein, tumor size, tumor necrosis, and hemorrhage were found to be the risk factors of multiple recurrences according to the univariate analysis, but lacked significance according to the multivariate analysis. When the cutoffs for early and multiple recurrences were changed to ≤10 months and ＞3 nodules, respectively, different risk factors were identified. Conclusions: Our results implicated that different factors can predict the recurrence, timing, and multiplicity of an HCC recurrence. Further studies should be conducted to prove the complex relationships between tumor burden, invasiveness, and underlying liver cirrhosis for initial tumors, and the timing and multiplicity of recurrent HCC. 
INTRODUCTION
Surgical resection is the best management option, in patients with hepatocellular carcinoma (HCC), provided that the remnant liver function is adequate. 1, 2 However, intrahepatic recurrence is a major cause of prognosis compromise in HCC, even after liver transplantation. 3, 4 Hence, extensive studies have been performed to identify the risk factors that predict HCC recurrence. The studies conducted to date have stratified the patients into recurrent and non-recurrent groups, [4] [5] [6] or according to the location of the recurrence (intrahepatic vs. extrahepatic), 3, 4 time to recurrence (early vs. late), 5, [7] [8] [9] or number of detected recurrent nodules (single vs. multiple vs. diffuse). [10] [11] [12] The identification of factors related to recurrence is important for predicting the prognosis and for establishing treatment plans. 10 However, published factor analysis results are often inconsistent, presumably due to different patient populations and small cohort sizes.
The aim of this study was to identify the risk factors of the intrahepatic recurrence of single nodular HCC, for all recurrences, whether early or multiple, and to compare the results in order to identify the common denominators of poor prognoses. To avoid pathologic uncertainty, we included only patients that underwent surgical resection as an initial management. In addition, the patients were restricted to single nodular HCC at presentation and intrahepatic recurrence only, to avoid confounding variables. were considered statistically significant.
RESULTS

Patient characteristics
The demographic data and clinicopathological parame- *Maximum value was set to 40,000 ng/ml. **Maximum value was set to 2,000 mAU/ml. ***Tumor staging according to 7 th AJCC tumor staging system. HBV, hepatitis B virus; HCV, hepatitis C virus; ALC, alcoholic liver disease; MELD, model for end-stage liver disease; AFP, alpha-fetoprotein; PIVKA, protein induced by vitamin K absence or antagonist ters of the 92 patients are presented in Table 2 . The overall mean patient age was 55.2 years, and there were 78 men and 14 women (a male to female sex ratio of 5.6:1).
The most common cause of background liver diseases were hepatitis B infection (n=67). In contrast, 15 patients (16.3%) had non-cirrhotic livers. In 76 patients (82.7%), one or more liver segments were resected, and in 16 patients (17.4%), only the HCC mass was removed by way of partial hepatectomy, with as much safety margin as possible.
Risk factor analysis for tumor recurrence Over a mean follow-up of 42.4 months, 41 patients (44.6%) were found to have an intrahepatic recurrence of HCC ( Table 3) .
The RFP curve, according to pT stages, is shown in Fig. 1 .
Risk factor analysis for early tumor recurrence
Of the 41 recurred patients, 29 (70.7%) recurred within *Maximum value was set to 40,000 ng/ml. **Maximum value was set to 2,000 mAU/ml. ***Tumor staging according to 7 th AJCC tumor staging system. HBV, hepatitis B virus; HCV, hepatitis C virus; ALC, alcoholic liver disease; MELD, model for end-stage liver disease; AFP, alpha-fetoprotein; PIVKA, protein induced by vitamin K absence or antagonist (Table 2) . However, tumor differentiation (p=0.043) was the sole independent risk factor according to the multivariate analysis (Table 4) .
When the RFP for early recurrence was set again to within 10 months, 21 patients (51.2%) had an early recurrence with the median RFP of 3 months (in a range of 1-10 months), and the median RFP for the late recurrence group was 27 months (in a range of 11-86 months). Differentiation (p=0.004), portal vein invasion (p=0.021), and microvascular invasion (p=0.003) were significant risk factors according to the univariate analysis (data not presented). In the multivariate analysis, tumor differentiation (p=0.038) was also the only independent risk factor. by the log-rank test (p=0.117, Fig. 2B ). The distributions of the recurrent nodule numbers are presented in Fig. 3 .
Comparison of risk factors for tumor recurrence A summary of the risk factors for recurrence, early recurrence, and multiple recurrences are presented in Table   5 . No single factor was found to predict the risks of recurrence, early recurrence, and multiple recurrences.
Although portal vein invasion was found to be a strong predictor of recurrence, it only predicted early recurrence when a cutoff of 10 months was used. Likewise, although differentiation was found to be an independent risk factor of early recurrence regardless of the RFP criterion, it did not predict recurrence per se, or multiple recurrences.
Also, different risk factors were identified by a univariate analysis in each recurrence group, when different criteria were applied. However, no independent risk factor was found to predict recurrence in the multiple recurrence group.
DISCUSSION
Although the prognosis for HCC patients has been improved by the establishment of various management and follow-up strategies, especially those based on considerations of viral hepatitis activity and liver cirrhosis severity, long term outcomes are compromised by intra-and extrahepatic recurrence. 5, 14 In this study, the intrahepatic recurrence rate was 44.6%, which is lower than most of those previously reported. 3, 5 The possible cause of the lower recurrence rate observed in this study is that macroscopic and microscopic satellite lesions, which are significant predictors of intrahepatic recurrence, were excluded. 12 Intrahepatic recurrence has been reported to outnumber extrahepatic recurrence by six to seven fold and, 15 thus, intrahepatic recurrence has been the subject of extensive study. 5 However, the majority of studies on potential risk factors compared the treatment modalities and/or recurrence patterns, and the reported results vary considerably.
Furthermore, the incongruity of the risks identified seems to be due to the different criteria applied, the discriminatory powers of the statistical methods used, and the diversity of the causative agents and patient population. 16, 17 This study shows that changing group criteria, even in the same patient population, results in the identification of different risk factors. 4 More specifically, the risk factors of early recurrence were changed by simply modifying the RFP criterion from within 18 months to within 10 months.
Likewise, when the recurrence multiplicity cutoff was altered from ＞1 to ＞3, different risk factors were identified by the univariate analysis. These results suggest that recurrence, timing, and multiplicity are driven by different factors. 5 The tumor size at the initial presentation has been relatively consistently identified as a risk factor of intrahepatic recurrence, 4, 18 and this study confirms tumor size as a risk factor along with portal vein invasion, which together constitute the tumor (T) stage as defined by the International Union for Cancer Control (UICC). 4, 19, 20 However, when a risk factor analysis for intrahepatic recurrence was performed versus extrahepatic recurrence, rather than non-recurrence, these significances disappeared. 3, 4, 15 The Child-Pugh score, as an independent risk factor of intrahepatic recurrence, means that liver cirrhosis is a risk factor. 4 Cumulative evidence suggests that the primary tumor burden (as indicated by the tumor size and the AFP), as well as the degree of liver cirrhosis (as indicated by the Child-Pugh score and the indocyanine green retention test) are the major conditions that provoke the intrahepatic recurrence of HCC, irrespective of the initial management modality. 6, 7, [21] [22] [23] Of note, the width and involvement of the resection margins and methods (anatomical resection versus partial hepatectomy), which are long debated issues in the context of recurrence, were not identified as risk factors in this study. 18, 24 When HCC recurrence was subdivided into early and late recurrence, using an RFP cutoff of 18 months, the risk factors identified differed from those of recurrence per se. In this study, tumor differentiation was an independent risk factor of early recurrence for RFP cutoffs of 18 and 10 months, and tumor differentiation is known to be related to tumor invasiveness; 15 however, tumor size and portal vein invasion were not found to be risk factors, even by the univariate analysis. On the other hand, Shirabe et al. 8 reported that capsule invasion, a tumor location deep in the liver parenchyma, and portal vein invasion independently predicted early HCC recurrence. These discrepancies between the identified risk factors may be due to the definitions of early recurrence used, and the different study populations. 25 Although the term 'early' is non-specific, discrimination is required to define the timing of recurrent HCC, because synchronous metastasis has a poorer prognosis than metachronous occurrence. 26 Some authors have defined synchronous and metachronous recurrences, using modes of recurrence like intrahepatic metastasis and multicentric occurrence, respectively, and not time courses. 27 We do not agree with the use of the same definitions for timing and modes of recurrence, and hope that further studies (based on tumor nucleic acid sequencing) contribute to the refining of the terminologies used. 28 In our series, the serum AFP level, tumor size, tumor necrosis, and hemorrhage were significant risk factors for multiple recurrence, according to the univariate analysis.
When a multiplicity cut off of ＞3 was used, rather than a cutoff of ＞1, the MELD score and the gross type replaced the tumor size and hemorrhage. Interestingly, the former factors are related to tumor mass, 29 while the latter are indicative of liver cirrhosis and tumor invasiveness, respectively. 12, 30 Our failure to identify independent risk factors in this study may have been due to the limited number of cases, especially in the diffuse recurrence subgroup, but it might also have been due to the complex relationships between the risk factors. 31 The distribution of the number of recurrent nodules among the 41 patients had two peaks at one nodule, and for diffuse recurrence throughout the remnant liver. Many authors have set the cutoff number for multiple recurrences to ＞3 nodules, 6,10,11,29 and we found that counting more than five nodules is impractical. Whatever number criterion is used to define multiplicity, the presence of two peaks in the nodule number distribution indicates that there are distinct groups with different etiologies and prognoses. 11, 12, 29 There were some limitations to this study. Since this was a small-volume retrospective study reported by a single center, high-volume multicenter studies need to be performed to validate our results. We presented only the recurrence-free survival results in this study, to avoid complexity of data presentation; thus, the overall patient survival results were omitted.
In conclusion, our results imply that different factors can predict recurrence, timing, and multiplicity of HCC recurrence. Further studies should be conducted to prove the complex relationships between tumor burden, invasiveness, and underlying liver cirrhosis of initial tumors, as well as the timing and multiplicity of recurrent HCC.
